{"id":"NCT02518945","sponsor":"University at Buffalo","briefTitle":"Dapagliflozin As Additional Treatment To Liraglutide And Insulin In Patients With Type 1 Diabetes","officialTitle":"Dapagliflozin As Additional Treatment To Liraglutide And Insulin In Patients With Type 1 Diabetes. A Randomized Clinical Trial","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-08","primaryCompletion":"2015-12","completion":"2016-04","firstPosted":"2015-08-10","resultsPosted":"2024-01-24","lastUpdate":"2024-01-24"},"enrollment":26,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Type 1 Diabetes Mellitus"],"interventions":[{"type":"DRUG","name":"Dapagliflozin","otherNames":["Farxiga"]},{"type":"DRUG","name":"Insulin","otherNames":["Lantus, Levemir, Toujjeo, Humalog , Novolog, Apidra"]},{"type":"DRUG","name":"Liraglutide","otherNames":["Victoza"]},{"type":"DRUG","name":"Dapagliflozin placebo","otherNames":["Placebo"]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Active drugs","type":"ACTIVE_COMPARATOR"}],"summary":"This is a single center, prospective, randomized, double blinded placebo controlled study conducted I patients with type 1 diabetes.The aim of this study is to examine the additive effects of GLP-1 agonist and SGLT2 inhibitor in patients with type 1 diabetes in terms of possible improved glycemic control, reduced glycemic variability, reduced insulin dosages, additional effects of weight loss and blood pressure reduction.","primaryOutcome":{"measure":"Absolute Change After 12 Weeks From Baseline in Mean HbA1c With Addition of Dapagliflozin Compared to Placebo.","timeFrame":"12 weeks","effectByArm":[{"arm":"Placebo","deltaMin":0,"sd":0.2},{"arm":"Active Drugs","deltaMin":-0.66,"sd":0.1}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":17},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["27490915"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":9},"commonTop":[]}}